International Biotechnology Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-67,000
Closed -$6.89M 70
2023
Q2
$6.89M Buy
+67,000
New +$6.89M 2.1% 16
2023
Q1
Sell
-314,973
Closed -$35.8M 70
2022
Q4
$35.8M Sell
314,973
-140,000
-31% -$15.9M 11.07% 1
2022
Q3
$28.2M Buy
454,973
+432,058
+1,885% +$26.7M 9.03% 1
2022
Q2
$287K Sell
22,915
-160,558
-88% -$2.01M 2.99% 11
2022
Q1
$7.45M Buy
183,473
+83,600
+84% +$3.4M 1.68% 24
2021
Q4
$10.8M Sell
99,873
-138,000
-58% -$14.9M 2.4% 16
2021
Q3
$26M Hold
237,873
6.28% 3
2021
Q2
$22.3M Sell
237,873
-155,127
-39% -$14.5M 5.88% 4
2021
Q1
$36.2M Sell
393,000
-51,000
-11% -$4.69M 9.57% 1
2020
Q4
$32.5M Buy
444,000
+55,000
+14% +$4.02M 8.87% 1
2020
Q3
$30.2M Sell
389,000
-45,000
-10% -$3.5M 9.76% 1
2020
Q2
$24M Buy
434,000
+40,000
+10% +$2.21M 7.98% 1
2020
Q1
$11.7M Buy
394,000
+4,000
+1% +$118K 5.32% 8
2019
Q4
$14.1M Buy
390,000
+172,000
+79% +$6.22M 5.08% 6
2019
Q3
$5.94M Buy
218,000
+90,000
+70% +$2.45M 2.74% 14
2019
Q2
$3.08M Hold
128,000
1.14% 23
2019
Q1
$3.38M Buy
128,000
+59,000
+86% +$1.56M 1.25% 26
2018
Q4
$1.06M Hold
69,000
0.66% 32
2018
Q3
$1.04M Hold
69,000
0.49% 42
2018
Q2
$1.14M Hold
69,000
0.44% 43
2018
Q1
$979K Hold
69,000
0.38% 52
2017
Q4
$1.01M Hold
69,000
0.36% 53
2017
Q3
$876K Sell
69,000
-100,000
-59% -$1.27M 0.34% 49
2017
Q2
$2M Buy
169,000
+84,000
+99% +$996K 0.76% 39
2017
Q1
$1.26M Hold
85,000
0.48% 43
2016
Q4
$1.37M Buy
+85,000
New +$1.37M 0.62% 32